Nimmerjahn F - Search Results

1

Intravenous immunoglobulin in neurology--mode of action and clinical efficacy.

Lünemann JD, Nimmerjahn F, Dalakas MC. Lünemann JD, et al. Among authors: nimmerjahn f. Nat Rev Neurol. 2015 Feb;11(2):80-9. doi: 10.1038/nrneurol.2014.253. Epub 2015 Jan 6. Nat Rev Neurol. 2015. PMID: 25561275 Review.

2

Anti-inflammatory actions of intravenous immunoglobulin.

Nimmerjahn F, Ravetch JV. Nimmerjahn F, et al. Annu Rev Immunol. 2008;26:513-33. doi: 10.1146/annurev.immunol.26.021607.090232. Annu Rev Immunol. 2008. PMID: 18370923 Review.

3

Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy.

Tackenberg B, Jelcic I, Baerenwaldt A, Oertel WH, Sommer N, Nimmerjahn F, Lünemann JD. Tackenberg B, et al. Among authors: nimmerjahn f. Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4788-92. doi: 10.1073/pnas.0807319106. Epub 2009 Mar 4. Proc Natl Acad Sci U S A. 2009. PMID: 19261857 Free PMC article.

4

The pro and anti-inflammatory activities of immunoglobulin G.

Lux A, Aschermann S, Biburger M, Nimmerjahn F. Lux A, et al. Among authors: nimmerjahn f. Ann Rheum Dis. 2010 Jan;69 Suppl 1:i92-96. doi: 10.1136/ard.2009.117101. Ann Rheum Dis. 2010. PMID: 19995755 Review.

5

The other side of immunoglobulin G: suppressor of inflammation.

Aschermann S, Lux A, Baerenwaldt A, Biburger M, Nimmerjahn F. Aschermann S, et al. Among authors: nimmerjahn f. Clin Exp Immunol. 2010 May;160(2):161-7. doi: 10.1111/j.1365-2249.2009.04081.x. Epub 2009 Dec 16. Clin Exp Immunol. 2010. PMID: 20041883 Free PMC article. Review.

6

B cell expression of the inhibitory Fc gamma receptor is unchanged in early MS.

Comabella M, Montalban X, Kakalacheva K, Osman D, Nimmerjahn F, Tintoré M, Lünemann JD. Comabella M, et al. Among authors: nimmerjahn f. J Neuroimmunol. 2010 Jun;223(1-2):135-7. doi: 10.1016/j.jneuroim.2010.03.015. J Neuroimmunol. 2010. PMID: 20399509

7

Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.

Tackenberg B, Nimmerjahn F, Lünemann JD. Tackenberg B, et al. Among authors: nimmerjahn f. J Clin Immunol. 2010 May;30 Suppl 1:S65-9. doi: 10.1007/s10875-010-9398-1. J Clin Immunol. 2010. PMID: 20424898 Review.

8

Mechanisms of action of intravenous immunoglobulins.

Baerenwaldt A, Biburger M, Nimmerjahn F. Baerenwaldt A, et al. Among authors: nimmerjahn f. Expert Rev Clin Immunol. 2010 May;6(3):425-34. doi: 10.1586/eci.10.9. Expert Rev Clin Immunol. 2010. PMID: 20441428 Review.

9

Expression and function of the inhibitory Fcγ-receptor in CIDP.

Nimmerjahn F, Lünemann JD. Nimmerjahn F, et al. J Peripher Nerv Syst. 2011 Jun;16 Suppl 1:41-4. doi: 10.1111/j.1529-8027.2011.00305.x. J Peripher Nerv Syst. 2011. PMID: 21696497

10

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Schwab I, Nimmerjahn F. Schwab I, et al. Among authors: nimmerjahn f. Nat Rev Immunol. 2013 Mar;13(3):176-89. doi: 10.1038/nri3401. Epub 2013 Feb 15. Nat Rev Immunol. 2013. PMID: 23411799 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters